Australia Lists Celltrion’s Truxima For Cancer

Reimbursement Limited To Chemotherapy Program

 
• By Aidan Fry
  
Doctor_Syring_Australia
Australia has listed Celltrion's Truxima rituximab biosimilar for reimbursement under a chemotherapy program • Source: Shutterstock

More from Biosimilars

More from Products